Clinical Trial Update: A Study To Examine Serologic Response In Hospitalized Patients Receiving Polyvalent Pneumococcal Vaccine

View source ↗

Summary

This completed clinical trial evaluated the serologic (antibody) response in hospitalized patients who received a polyvalent pneumococcal vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Polyvalent Pneumococcal Vaccine (pneumococcal polysaccharide vaccine polyvalent)

Snippet

Sponsor: George Washington University | Conditions: Pneumonia | Status: COMPLETED